Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

By Christy Santhosh (Reuters) -Centene shares tumbled 38% on Wednesday, on track for their largest single-day plunge, after the U.S. health insurer pulled its 2025 earnings forecast due to an ...

Morgan Stanley downgraded Centene (NYSE:CNC) and Molina Healthcare (NYSE:MOH) to Equal-Weight from Overweight on Thursday, arguing that the two Medicaid-focused rivals' near-term challenges offset ...